Improving risk‐stratification of natalizumab‐associated PML
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51130
Abstract: Based on publicly available data, we reevaluated current algorithms for stratifying the risk of progressive multifocal leukoencephalopathy (PML) in natalizumab‐treated patients with multiple sclerosis, and found that there are a number of issues. First and… read more here.
Keywords: risk; natalizumab associated; risk stratification; stratification natalizumab ... See more keywords
Incidence of natalizumab-associated progressive multifocal leucoencephalopathy and its relationship with the pattern of natalizumab exposure over time
Sign Up to like & getrecommendations! Published in 2019 at "Revue Neurologique"
DOI: 10.1016/j.neurol.2019.01.270
Abstract: Introduction Since the 2012 identification of 3 risk factors for natalizumab-associated progressive multifocal leucoencephalopathy (PML) changes in the PML incidence rate have been of interest. Objectives Determine the natalizumab-associated PML incidence in the global postmarketing… read more here.
Keywords: incidence; natalizumab associated; associated progressive; natalizumab exposure ... See more keywords